Litcius/Paper detail

Weekly SARS-CoV-2 screening of asymptomatic kindergarten to grade 12 students and staff helps inform strategies for safer in-person learning

Shira Doron, Robin R. Ingalls, Anne S. Beauchamp, Jesse S. Boehm, Helen W. Boucher, Linda H. Chow, Linda Corridan, Katey Goehringer, D T Golenbock, Liz Larsen, David Lussier, Marcia A. Testa, Andrea Ciaranello

2021Cell Reports Medicine27 citationsDOIOpen Access PDF

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in K-12 schools was rare during in 2020-2021; few studies included Centers for Disease Control and Prevention (CDC)-recommended screening of asymptomatic individuals. We conduct a prospective observational study of SARS-CoV-2 screening in a mid-sized suburban public school district to evaluate the incidence of asymptomatic coronavirus disease 2019 (COVID-19), document frequency of in-school transmission, and characterize barriers and facilitators to asymptomatic screening in schools. Staff and students undergo weekly pooled testing using home-collected saliva samples. Identification of >1 case in a school prompts investigation for in-school transmission and enhancement of safety strategies. With layered mitigation measures, in-school transmission even before student or staff vaccination is rare. Screening identifies a single cluster with in-school staff-to-staff transmission, informing decisions about in-person learning. The proportion of survey respondents self-reporting comfort with in-person learning before versus after implementation of screening increases. Costs exceed $260,000 for assays alone; staff and volunteers spend 135-145 h per week implementing screening.

Topics & Concepts

AsymptomaticTransmission (telecommunications)MedicineIncidence (geometry)Observational studyFamily medicineCoronavirus disease 2019 (COVID-19)Contact tracingPublic healthPediatricsDiseaseNursingInfectious disease (medical specialty)Internal medicinePhysicsElectrical engineeringOpticsEngineeringSARS-CoV-2 detection and testingRespiratory viral infections researchSARS-CoV-2 and COVID-19 Research